S
ROIV icon

Sachetta’s Roivant Sciences ROIV Stock Holding History

Sachetta’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06K Buy
143
+19
+15% +$561 ﹤0.01% 650
2026
Q1 		$3.44K Hold
124
– – ﹤0.01% 767
2025
Q4 		$2.69K Hold
124
– – ﹤0.01% 686
2025
Q3 		$1.88K Hold
124
– – ﹤0.01% 844
2025
Q2 		$1.4K Buy
+124
New +$1.34K ﹤0.01% 910
2025
Q1 		– Sell
-81
Closed -$959 – 1194
2024
Q4 		$959 Hold
81
– – ﹤0.01% 1001
2024
Q3 		$935 Buy
+81
New +$922 ﹤0.01% 1044

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Sachetta's ROIV Position: Q2 2026 in Review

Sachetta increased its Roivant Sciences (ROIV) stake by 15% in Q2 2026, buying an estimated $561 and bringing the position to 143 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Sachetta first reported a position in ROIV in Q3 2024 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Sachetta held 143 shares of Roivant Sciences worth $5.06K as of Q2 2026.
  • Sachetta bought 19 Roivant Sciences shares in Q2 2026, an estimated $561.
  • Roivant Sciences made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #650 holding.
  • Sachetta first reported a position in Roivant Sciences in Q3 2024 and has held it in 7 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.